Literature DB >> 20926308

Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein.

Haruki Hasegawa1, Heather J Thomas, Ken Schooley, Teresa L Born.   

Abstract

Although IL-32 has been shown to be induced under various pathological conditions, a detailed understanding of native IL-32 intracellular distribution and mechanism of release from cells has not been reported. We examined the expression of IL-32 in the intestinal epithelial cell line HT-29 following TNFα and IFNγ co-stimulation. The subcellular localization of induced IL-32 was associated with the membrane of lipid droplet-like structures and vacuolar structures that co-localized with markers of endosomes and lysosomes. Prolonged co-stimulation resulted in cell death and appearance of IL-32 in the culture medium. IL-32 released from co-stimulated HT-29 cells was found in a detergent-sensitive particulate fraction, and in a step density gradient the IL-32 particulate was buoyant, suggesting association with a membrane-bound vesicle. Upon Triton X-114 partitioning, most of the IL-32 partitioned to the detergent phase, suggesting hydrophobic characteristics. When IL-32-containing vesicles were subjected to protease K treatment, a protease resistant ∼12kDa fragment was generated from ∼24kDa IL-32. We propose that under these conditions, native IL-32 is released via a non-classical secretory route perhaps involving multi-vesicular bodies and exosomes. Demonstration of membrane association for both intracellular and released IL-32 suggests this unique cytokine may have a complex biosynthetic pathway and mechanism of action.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20926308     DOI: 10.1016/j.cyto.2010.09.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  22 in total

1.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

2.  Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.

Authors:  Bas Heinhuis; Marije I Koenders; Wim B van den Berg; Mihai G Netea; Charles A Dinarello; Leo A B Joosten
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

3.  Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss.

Authors:  Muhammad Zahoor; Marita Westhrin; Kristin Roseth Aass; Siv Helen Moen; Kristine Misund; Katarzyna Maria Psonka-Antonczyk; Mariaserena Giliberto; Glenn Buene; Anders Sundan; Anders Waage; Anne-Marit Sponaas; Therese Standal
Journal:  Blood Adv       Date:  2017-12-13

Review 4.  Transfer of extracellular vesicles during immune cell-cell interactions.

Authors:  Cristina Gutiérrez-Vázquez; Carolina Villarroya-Beltri; María Mittelbrunn; Francisco Sánchez-Madrid
Journal:  Immunol Rev       Date:  2013-01       Impact factor: 12.988

5.  Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.

Authors:  Kosuke Sakitani; Yoshihiro Hirata; Yoku Hayakawa; Takako Serizawa; Wachiko Nakata; Ryota Takahashi; Hiroto Kinoshita; Kei Sakamoto; Hayato Nakagawa; Masao Akanuma; Haruhiko Yoshida; Shin Maeda; Kazuhiko Koike
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

Review 6.  Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.

Authors:  Asfar S Azmi; Bin Bao; Fazlul H Sarkar
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 7.  Exosomes as potent regulators of HCC malignancy and potential bio-tools in clinical application.

Authors:  Zhen Qu; Chunping Jiang; Junhua Wu; Yitao Ding
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Intracellular interaction of interleukin (IL)-32α with protein kinase Cε (PKCε ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells.

Authors:  Jeong-Woo Kang; Yun Sun Park; Dong Hun Lee; Jung-Hee Kim; Man Sub Kim; Yesol Bak; Jintae Hong; Do-Young Yoon
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

9.  Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges.

Authors:  Golam Kibria; Erika K Ramos; Yong Wan; David R Gius; Huiping Liu
Journal:  Mol Pharm       Date:  2018-05-30       Impact factor: 4.939

Review 10.  Novel insights into the biology of interleukin-32.

Authors:  Leo A B Joosten; Bas Heinhuis; Mihai G Netea; Charles A Dinarello
Journal:  Cell Mol Life Sci       Date:  2013-03-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.